Results 171 to 180 of about 34,996 (233)

Inherited Thrombophilia and the Risk of Venous Thromboembolism in Patients with Non-Small Cell Lung Cancer, a Case-Control Study. [PDF]

Clin Appl Thromb Hemost
Costa J, Carvalho M, Cadavez E, Gomes J, Leite RP, Araújo A.   +5 more
europepmc   +1 more source

Rethinking residual p53 function in HPV-positive cervical cancer cells. [PDF]

J Virol
Farrukh S, Kavcic N, Canarutto G, Piazza S, Banks L.   +4 more
europepmc   +1 more source

Mismatch Repair as a Dynamic and Clinically Actionable Vulnerability in Cancer. [PDF]

Cancer Res
Piumatti E, Vitiello PP, Amodio V, Bardelli A, Germano G.   +4 more
europepmc   +1 more source

Couples' experiences with ostomy due to colorectal cancer in one of the partners: a scoping review. [PDF]

Rev Esc Enferm USP
Mestre RES, Dias ABG, Oliveira CMGS, Alves PV.   +3 more
europepmc   +1 more source

Controlled dynamic remodeling of the spliceosome active site enables the first step of splicing. [PDF]

Proc Natl Acad Sci U S A
Martino G, Manigrasso J, La Sala G, Marcia M, De Vivo M.   +4 more
europepmc   +1 more source

Dual inhibition of mTOR and HSP90 enhances cisplatin efficacy and overcomes resistance in ovarian cancer. [PDF]

Cell Death Dis
Lombardi R, Addi L, Pucci B, Bruzzese F, Sonego M, Nespolo A, Roca MS, Iannelli F, Alfano L, Capone F, Di Gennaro E, Baldassarre G, Budillon A.   +12 more
europepmc   +1 more source

Il cancro della prostata. [PDF]

, 1987
ZATTONI, FILIBERTO, Pagano F:, Oliva G, Piazza R, Vianello F   +4 more
core  

HnRNP C binding to inverted <i>Alu</i> elements protects the transcriptome from pre-mRNA circularization. [PDF]

Sci Adv
Marini A, Pitolli C, Ciccone S, Pieraccioli M, Robil N, Naro C, Palluzzi F, Giansanti M, Tamburrini G, Giacò L, de la Grange P, Nazio F, Bielli P, Sette C, Pagliarini V.   +14 more
europepmc   +1 more source

Structure-Guided SOCS3 Peptidomimetics: Design and Functional Characterization. [PDF]

ACS Omega
Cugudda A, La Manna S, Bucciero C, Castellano G, Malfitano AM, Marasco D.   +5 more
europepmc   +1 more source

Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model. [PDF]

Blood Cancer J
Tavernari L, Bertesi M, Neroni A, Papa E, Rontauroli S, Bianchi E, Mirabile M, Norfo R, Parenti S, Tombari C, Carretta C, Malerba M, Fabbiani L, Guglielmelli P, Losi L, Tagliafico E, Vannucchi AM, Manfredini R, MYNERVA (MYeloid NEoplasms Research Venture AIRC) investigators.   +18 more
europepmc   +1 more source